Cambio Interim Report Q3 2024

• Revenue amounted to 273.9 (256.4) MSEK in the third quarter, representing growth of 6.8%

• Adjusted EBITDA amounted to 59.3 (70.9) MSEK, representing growth of -16.4%

• Income before tax amounted to -15.3 (2.9) MSEK

• Net income per share was negative (neg)

Read more in the attached report.

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.